NLRP3 showed no changes in gene expression between control-RPE or AMD-RPE cells, while absent in melanoma 2 (AIM2) was 2.18-fold higher expressed in AMD-RPE cells when compared to control-RPE cells exposed to IL-1α priming and vehicle. The gene discussed is IL1A; the disease is melanoma.